IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment
The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is: \- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour? Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).
• Age \> 18 years.
• Have at least 1 suspected bladder tumour seen at cystoscopy.
• Have a bladder that is accessible for cystoscopy.
• Be in a physical condition to undergo a TURBT.
• Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation/intervention.